NewsWhore
07-17-2012, 02:10 PM
In Brazil and Mexico, Prescribing of DPP-IV Inhibitors for the Treatment of Type 2 Diabetes is Uncommon in the Public Healthcare Setting Due to Lack of Government Funding in Both Countries and High ...
More... (http://www.brazilsun.com/index.php?sid/207507618/scat/24437442923341f1)
More... (http://www.brazilsun.com/index.php?sid/207507618/scat/24437442923341f1)